Scrap rate and first-pass yield are core operations KPIs that also signal process drift. Spikes feed CAPA, supplier-quality investigations, and process-validation re-evaluation triggers. First-pass yield counts the share of units made right the first time without rework, while rolled throughput yield multiplies yields across all steps. Tracking yields by line, shift and supplier lot helps find root causes. Scrap costs feed cost-of-poor-quality reports, and sudden improvements should also be checked to make sure inspections are still working.

Why it matters

Quality teams should treat sustained yield decline as a leading indicator of nonconformance trends, not just a financial issue.

Common pitfalls

•Treating scrap rate and yield solely as financial metrics overlooks their significance as quality indicators.
•Failing to initiate appropriate corrective and preventive actions (CAPAs) when scrap rate or yield consistently fall outside established limits is a common oversight.
•Not adequately linking scrap rate and yield data to process validation re-evaluation criteria can lead to undetected process drift.
•Ignoring the potential impact of supplier quality on scrap rate and yield can result in ineffective root cause analysis.
•Failing to trend and analyze scrap rate and yield data over time can mask gradual but significant process degradation.

Sources

ASQ Yield Definitions · ASQ
ISO 13485 Standard Page · ISO
GHTF/IMDRF Process Validation Guidance · IMDRF/GHTF

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.